{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:55:26Z","timestamp":1792176926293,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106345","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:04:14Z","timestamp":1782493454000},"page":"106345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis"],"prefix":"10.1016","volume":"129","author":[{"given":"Andr\u00e9","family":"van der Wurff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gambusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Budeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Watzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Miteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon P.","family":"Scicluna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Siakaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Vonderhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Klenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Herbstreit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Dudda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-3380","authenticated-orcid":false,"given":"Stefanie B.","family":"Floh\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2026.106345_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106345_bib2","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis","volume":"13","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106345_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib5","article-title":"Sepsis-pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib6","first-page":"56","article-title":"Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil Med Res"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106345_bib7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.ebiom.2026.106345_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep38361","article-title":"Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2026.106345_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104363","article-title":"Immunopathophysiology of human sepsis","volume":"86","author":"Wiersinga","year":"2022","journal-title":"eBioMedicine"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106345_bib10","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106345_bib11","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106345_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"Lodoen","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6374379","article-title":"NK-DC crosstalk in immunity to microbial infection","volume":"2016","author":"Thomas","year":"2016","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106345_bib17","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.intimp.2006.01.013","article-title":"Human NK cell IFN-gamma production is regulated by endogenous TGF-beta","volume":"6","author":"Meadows","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106345_bib19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.1402099","article-title":"Activation-specific metabolic requirements for NK Cell IFN-\u03b3 production","volume":"194","author":"Keppel","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O'Brien","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib21","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4049\/jimmunol.1700497","article-title":"Cutting edge: IL-2-induced expression of the amino acid transporters SLC1A5 and CD98 is a prerequisite for NKG2D-Mediated activation of human NK cells","volume":"199","author":"Jensen","year":"2017","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib22","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.1501783","article-title":"Metabolic reprogramming supports IFN-\u03b3 production by CD56bright NK cells","volume":"196","author":"Keating","year":"2016","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106345_bib23","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106345_bib24","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1074\/jbc.RA118.005892","article-title":"Interleukin-18 up-regulates amino acid transporters and facilitates amino acid-induced mTORC1 activation in natural killer cells","volume":"294","author":"Almutairi","year":"2019","journal-title":"J Biol Chem"},{"issue":"415","key":"10.1016\/j.ebiom.2026.106345_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106345_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Mar\u00e7ais","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2014.00187","article-title":"The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions","volume":"5","author":"Nandagopal","year":"2014","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2\u20134","key":"10.1016\/j.ebiom.2026.106345_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejcb.2018.12.003","article-title":"Natural killer cells in sepsis: underprivileged innate immune cells","volume":"98","author":"Kumar","year":"2019","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.ebiom.2026.106345_bib31","article-title":"Natural killer cells in sepsis: friends or foes?","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106345_bib32","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.4049\/jimmunol.180.9.6334","article-title":"NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis","volume":"180","author":"Etogo","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib33","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1172\/JCI128075","article-title":"Post-sepsis immunosuppression depends on NKT cell regulation of mTOR\/IFN-\u03b3 in NK cells","volume":"130","author":"Kim","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/cc11838","article-title":"Toll-like receptors expression and interferon-\u03b3 production by NK cells in human sepsis","volume":"16","author":"Souza-Fonseca-Guimaraes","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106345_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/apm.12002","article-title":"The functional role of natural killer cells early in clinical sepsis","volume":"121","author":"Giannikopoulos","year":"2013","journal-title":"APMIS"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106345_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00018-022-04490-0","article-title":"Metabolic reprogramming consequences of sepsis: adaptations and contradictions","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ebiom.2026.106345_bib37","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fimmu.2020.01200","article-title":"An inverse relationship between c-Kit\/CD117 and mTOR confers NK cell dysregulation late after severe injury","volume":"11","author":"B\u00f6sken","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ebiom.2019.04.018","article-title":"Circulating growth\/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation","volume":"43","author":"Kleinertz","year":"2019","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106345_bib39","first-page":"649","article-title":"Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes","volume":"9","author":"Haller","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130155","article-title":"Invasive surgery impairs the regulatory function of human CD56bright natural killer cells in response to staphylococcus aureus. Suppression of Interferon-\u03b3 synthesis","volume":"10","author":"Reinhardt","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/JLB.4A0818-313RR","article-title":"A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis","volume":"107","author":"Feng","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V86.2.646.bloodjournal862646","article-title":"Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes","volume":"86","author":"Hayes","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib43","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V89.5.1612","article-title":"Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness","volume":"89","author":"Ertel","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","article-title":"Sepsis-induced immune dysfunction: can immune therapies reduce mortality?","volume":"126","author":"Delano","year":"2016","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.immuni.2012.03.026","article-title":"NK cell-derived interferon-\u03b3 orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection","volume":"36","author":"Goldszmid","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib46","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/01.CCM.0000063579.43470.AA","article-title":"Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured Male trauma patients","volume":"31","author":"Spolarics","year":"2003","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib47","first-page":"13","article-title":"Major surgical trauma impairs the function of natural killer cells but does not affect monocyte cytokine synthesis","volume":"12","author":"M\u00fcller-Heck","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ebiom.2026.106345_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.887503","article-title":"Recruited and tissue-resident natural killer cells in the lung during infection and cancer","volume":"13","author":"Franklin","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753425913517274","article-title":"A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-\u03b3 production of NK cells in the lung during sepsis-induced immunosuppression","volume":"21","author":"Pastille","year":"2015","journal-title":"Innate Immun"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106345_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007405","article-title":"Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections","volume":"14","author":"Jensen","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1238","article-title":"Arrested development: suppression of NK cell function in the tumor microenvironment","volume":"10","author":"Riggan","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.ebiom.2026.106345_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5271203","article-title":"Growth differentiation Factor-15 is a predictor of mortality in critically ill patients with sepsis","volume":"2017","author":"Buendgens","year":"2017","journal-title":"Dis Markers"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106345_bib53","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00018-012-0963-z","article-title":"Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98","volume":"69","author":"Nguyen","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106345_bib54","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.188.7.1267","article-title":"Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells","volume":"188","author":"Mainiero","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106345_bib55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ni.3398","article-title":"Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis","volume":"17","author":"Cheng","year":"2016","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41590-025-02390-6","article-title":"Metabolic adaptations rewire CD4(+) T cells in a subset-specific manner in human critical illness with and without sepsis","volume":"27","author":"Stier","year":"2026","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib57","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.1700127","article-title":"IL-7 restores T lymphocyte immunometabolic failure in septic shock patients through mTOR activation","volume":"199","author":"Venet","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2026.106345_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2021.09.009","article-title":"PD-1, CTLA-4, LAG-3, and TIGIT: the roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions","volume":"240","author":"Esen","year":"2021","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106345_bib59","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20220007","article-title":"Effects of PD-1 signaling on immunometabolic reprogramming","volume":"4","author":"Boussiotis","year":"2022","journal-title":"Immunometabolism"},{"key":"10.1016\/j.ebiom.2026.106345_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1452993","article-title":"Targeting AMP-activated protein kinase in sepsis","volume":"15","author":"Yumoto","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ebiom.2026.106345_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbi.2017.11.003","article-title":"AMPK regulates immunometabolism in sepsis","volume":"72","author":"Huang","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106345_bib62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106345_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106345_bib64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-023-07065-0","article-title":"Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial","volume":"49","author":"Roquilly","year":"2023","journal-title":"Intensive Care Med"},{"issue":"21","key":"10.1016\/j.ebiom.2026.106345_bib65","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.3390\/cancers14215438","article-title":"Nanoparticle enhancement of natural killer (NK) cell-based immunotherapy","volume":"14","author":"Murugan","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:47Z","timestamp":1785908687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":65,"alternative-id":["S2352396426002288"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106345","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106345"}}